Australian medical professionals at the forefront of the coronavirus will receive a tuberculosis vaccine
Thousands of Australian doctors and nurses on the frontline of the coronavirus are on trial with a vaccine that could stop the spread of COVID-19
- Researchers will dust the ’80s tuberculosis vaccine to fight the coronavirus
- 4,000 Australian general practitioners receive the vaccine to combat the symptoms of COVID-19
- We hope the vaccine will boost the immune system of medical professionals
- Coronavirus symptoms: what are they and should you see a doctor?
In an effort to protect primary health care workers from coronavirus, researchers have been turning to a vaccine not used in Australia since the 1980s.
Murdoch Children’s Research Institute in Melbourne will participate in a worldwide trial of the tuberculosis vaccine to help combat coronavirus symptoms.
The six-month trial will involve 4,000 health workers in Australia, lead researcher Nigel Curtis told reporters on Thursday.
Half of the workers are not given the vaccine to researchers who want to get a sign of its effectiveness within three months.
We hope the vaccine will boost the immune system of medical professionals. In the photo: two nurses at Mount Barker Hospital in Adelaide
There have been approximately 2,800 confirmed cases of coronavirus in Australia, with 13 deaths as the country braced itself to accelerate the outbreak.
Professor Curtis said the vaccine, in addition to fighting tuberculosis, boosts the body’s immune system and reduces coronavirus symptoms.
“It really is the first time the vaccine has been used in this way,” said Professor Curtis.
“The vaccine can” train “the immune system to respond more strongly to infections.”
He said health workers are particularly vulnerable to infection, suggesting the deaths of first-line workers abroad.
4,000 Australian health professionals receive the tuberculosis vaccine to combat the symptoms of COVID-19. Pictured: A view of the COVID-19 clinic at Alfred Hospital on March 26
Similar studies are starting in the Netherlands, Germany and the UK, but the Australian trial will be one of the largest.
CORONAVIRUS CASES IN AUSTRALIA: 2.810
New South Wales: 1,219
Western Australia: 231
South Australia: 235
Australian Capital Territory: 53
Northern Territory: 12
TOTAL CASES: 2,810
Unlike the Northern Hemisphere, Australia will face coronavirus during the winter flu season, which would provide more data for researchers.
But he said it is still important for countries to develop a coronavirus vaccine.
“This has really warned the world that we are always only a few weeks away from a pandemic,” said Prof Curtis.
“Even if we make a vaccine against this particular virus, if another one pops up, it’s really good for us to have a ready-made vaccine that works against the number of different viruses.”
Prof Curtis said that people who already had coronavirus or did not feel well would be excluded from the trial.
He said that people’s initial rush to get chloroquine – a malaria vaccine that was unsuccessful in fighting the coronavirus – demonstrated the need for intensive studies.
“If I hadn’t thought (the tuberculosis vaccine) would work, I wouldn’t have been here seven days a week with a team of 20 people in the past month,” he said.
Unlike the Northern Hemisphere, Australia will encounter the Corona virus in the winter flu season. Two women with masks are seen in Sydney on Wednesday
There have been more than 2,800 confirmed cases of coronavirus in Australia, with 13 deaths as the country braced to accelerate the outbreak